A study of prostate delineation referenced against a gold standard created from the visible human data.

PURPOSE To measure inter- and intra-observer variation and systematic error in CT based prostate delineation, where individual delineations are referenced against a gold standard produced from photographic anatomical images from the Visible Human Project (VHP). MATERIALS AND METHODS The CT and anatomical images of the VHP male form the basic data set for this study. The gold standard was established based on 1mm thick anatomical photographic images. These were registered against the 3mm thick CT images that were used for target delineation. A total of 120 organ delineations were performed by six radiation oncologists. RESULTS The physician delineated prostate volume was on average 30% larger than the "true" prostate volume, but on average included only 84% of the gold standard volume. Our study found a systematic delineation error such that posterior portions of the prostate were always missed while anteriorly some normal tissue was always defined as target. CONCLUSIONS Our data suggest that radiation oncologists are more concerned with the unintentional inclusion of rectal tissue than they are in missing prostate volume. In contrast, they are likely to overextend the anterior boundary of the prostate to encompass normal tissue such as the bladder.

[1]  M van Herk,et al.  Definition of the prostate in CT and MRI: a multi-observer study. , 1999, International journal of radiation oncology, biology, physics.

[2]  A. E. Saarnak,et al.  Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  Computed tomography localization of radiation treatment delivery versus conventional localization with bony landmarks , 2003, Journal of applied clinical medical physics.

[4]  T Haycocks,et al.  Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  A W Beavis,et al.  Is tomotherapy the future of IMRT? , 2004, The British journal of radiology.

[6]  J O Deasy,et al.  Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. , 1993, Medical physics.

[7]  C. Fiorino,et al.  Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  Filip Claus,et al.  Interobserver Delineation Variation Using CT versus Combined CT + MRI in Intensity–Modulated Radiotherapy for Prostate Cancer , 2005, Strahlentherapie und Onkologie.

[9]  L Chen,et al.  Dosimetric evaluation of MRI-based treatment planning for prostate cancer , 2004, Physics in medicine and biology.

[10]  V. Moiseenko,et al.  Internal fiducial markers can assist dose escalation in treatment of prostate cancer: result of organ motion simulations , 2006, Physics in medicine and biology.

[11]  E Bellon,et al.  Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Mack Roach,et al.  Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond , 2005, CA: a cancer journal for clinicians.

[13]  M. Herk Errors and margins in radiotherapy. , 2004 .

[14]  E Bellon,et al.  The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[15]  V. Khoo,et al.  Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity? , 2004, International journal of radiation oncology, biology, physics.

[16]  V M Spitzer,et al.  The Visible Human data set: an image resource for anatomical visualization. , 1995, Medinfo. MEDINFO.

[17]  M van Herk,et al.  A general methodology for three-dimensional analysis of variation in target volume delineation. , 1999, Medical physics.

[18]  J C Stroom,et al.  Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. , 1999, International journal of radiation oncology, biology, physics.

[19]  K L Lam,et al.  Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. , 1995, International journal of radiation oncology, biology, physics.

[20]  E. Nieschlag,et al.  Prostate volume in testosterone‐treated and untreated hypogonadal men in comparison to age‐matched normal controls , 1994, Clinical endocrinology.

[21]  M. V. van Herk,et al.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[22]  H. Hricak,et al.  Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. , 1996, International journal of radiation oncology, biology, physics.

[23]  S. Morrill,et al.  MLC quality assurance techniques for IMRT applications. , 2003, Medical physics.

[24]  T. Hellebust,et al.  Comparative analyses of the dynamic properties of the rectum studied by cryo-sections of human cadavers and pelvic CT scans of patients. , 2003, The British journal of radiology.

[25]  E van der Schueren,et al.  Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  L. F. Cazzaniga,et al.  Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.